arginine and fenofibrate

arginine has been researched along with fenofibrate in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (45.45)29.6817
2010's6 (54.55)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ1
Ekins, S; Williams, AJ; Xu, JJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Bode-Böger, SM; Dierkes, J; Luley, C; Martens-Lobenhoffer, J; Westphal, S1
Chen, MF; Jiang, JL; Li, YJ; Luo, BL; Yang, TL; Yu, J1
Chen, MF; Jiang, JL; Li, YJ; Luo, BL; Xie, QY; Yang, TL1
Chen, MF; Li, YJ; Luo, BL; Xia, X; Yang, TL1
Huang, F; Jiang, J; Sun, B; Wang, Y; Xie, Y; Xu, X; Zhao, C1
Beaudeux, JL; Bonnefont-Rousselot, D; Borderie, D; Djelidi, R; Frombaum, M; Therond, P1

Reviews

1 review(s) available for arginine and fenofibrate

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Trials

2 trial(s) available for arginine and fenofibrate

ArticleYear
Fenofibrate increases the L-arginine:ADMA ratio by increase of L-arginine concentration but has no effect on ADMA concentration.
    Atherosclerosis, 2004, Volume: 173, Issue:2

    Topics: Adult; Arginine; Biomarkers; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Fenofibrate; Follow-Up Studies; Humans; Hyperlipidemias; Hypolipidemic Agents; Male; Middle Aged; Probability; Reference Values; Risk Assessment; Severity of Illness Index; Treatment Outcome

2004
Effect of fenofibrate on the level of asymmetric dimethylarginine in individuals with hypertriglyceridemia.
    European journal of clinical pharmacology, 2006, Volume: 62, Issue:3

    Topics: Adult; Anticholesteremic Agents; Arginine; Blood Flow Velocity; Brachial Artery; Cholesterol; Cholesterol, HDL; Diet; Endothelium, Vascular; Female; Fenofibrate; Humans; Hypertriglyceridemia; Male; Malondialdehyde; Middle Aged; Nitric Oxide; Treatment Outcome; Triglycerides; Tumor Necrosis Factor-alpha; Vasodilation

2006

Other Studies

8 other study(ies) available for arginine and fenofibrate

ArticleYear
Chemical genetics reveals a complex functional ground state of neural stem cells.
    Nature chemical biology, 2007, Volume: 3, Issue:5

    Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells

2007
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Developing structure-activity relationships for the prediction of hepatotoxicity.
    Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes

2010
A predictive ligand-based Bayesian model for human drug-induced liver injury.
    Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12

    Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands

2010
Effect of fenofibrate on LDL-induced endothelial dysfunction in rats.
    Naunyn-Schmiedeberg's archives of pharmacology, 2004, Volume: 370, Issue:2

    Topics: Acetylcholine; Animals; Anti-Inflammatory Agents; Aorta, Thoracic; Arginine; Creatinine; Endothelium, Vascular; Fenofibrate; Hypolipidemic Agents; In Vitro Techniques; Male; Malondialdehyde; Muscle, Smooth, Vascular; Nitrates; Nitrites; Phenylephrine; Rats; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha; Vasodilation

2004
Fenofibrate decreases asymmetric dimethylarginine level in cultured endothelial cells by inhibiting NF-kappaB activity.
    Naunyn-Schmiedeberg's archives of pharmacology, 2005, Volume: 371, Issue:5

    Topics: Arginine; Cell Survival; Cells, Cultured; Fenofibrate; Humans; Hypolipidemic Agents; L-Lactate Dehydrogenase; Muscle, Smooth, Vascular; NF-kappa B; Nitric Oxide; Tumor Necrosis Factor-alpha

2005
Pleiotropic effects of fenofibrate therapy on rats with hypertriglycemia.
    Lipids in health and disease, 2015, Apr-14, Volume: 14

    Topics: Animals; Apolipoprotein A-I; Arginine; C-Reactive Protein; Cardiotonic Agents; Cholesterol, HDL; Dose-Response Relationship, Drug; Fenofibrate; Hypertriglyceridemia; Hypolipidemic Agents; Male; Malondialdehyde; Nitric Oxide; Rats; Rats, Sprague-Dawley; Triglycerides

2015
Piceatannol is more effective than resveratrol in restoring endothelial cell dimethylarginine dimethylaminohydrolase expression and activity after high-glucose oxidative stress.
    Free radical research, 2011, Volume: 45, Issue:3

    Topics: Amidohydrolases; Animals; Antioxidants; Aorta; Arginase; Arginine; Blotting, Western; Cattle; Cell Line; Endothelial Cells; Glucose; Hyperglycemia; Immunoprecipitation; Naphthalenes; Nitric Oxide Synthase; Oxidative Stress; Pyrones; Resveratrol; Sirtuin 1; Stilbenes

2011